Literature DB >> 8215961

Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease.

Y Stern1, M Richards, M Sano, R Mayeux.   

Abstract

OBJECTIVE: To compare cognitive changes in the dementias of Parkinson's disease (PD) and Alzheimer's disease (AD).
DESIGN: Case series, group comparisons.
SETTING: Ambulatory care referral center. PATIENTS: Consecutive sample of 14 patients with PD dementia and 27 with probable AD matched for overall intellectual function using a mental status test, as well as 14 non-demented PD and 12 mild probable AD patients, similarly matched for overall intellectual function. All demented patients met Diagnostic and Statistical Manual, Revised Third Edition, criteria for dementia. MAIN OUTCOME MEASURES: Performance on a battery of neuropsychological tests assessing verbal and nonverbal memory, verbal fluency, and constructional ability.
RESULTS: Nondemented and demented patients with PD performed worse than their probable AD comparison groups on verbal fluency and visuospatial tasks. Cognitive changes attributable to dementia were similar in PD and probable AD but were not identical. The patients with probable AD demonstrated more marked change in memory performance with delay.
CONCLUSIONS: Our findings suggest that when dementia occurs in PD it is overlaid on cognitive changes that already exist in nondemented patients but that the dementing process in PD involves systems other than those responsible for cognitive change in nondemented PD patients. We hypothesize that in most cases, dementia in PD involves changes in a nondopaminergic neurotransmitter system but is not due to concomitant AD.

Entities:  

Mesh:

Year:  1993        PMID: 8215961     DOI: 10.1001/archneur.1993.00540100035011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  15 in total

Review 1.  Mild cognitive impairment in Parkinson's disease.

Authors:  J G Goldman; I Litvan
Journal:  Minerva Med       Date:  2011-12       Impact factor: 4.806

2.  Auditory confrontation naming in Alzheimer's disease.

Authors:  Jason Brandt; Arnold Bakker; David Aaron Maroof
Journal:  Clin Neuropsychol       Date:  2010-10-27       Impact factor: 3.535

3.  The Movement Disorders Society criteria for the diagnosis of Parkinson's disease dementia: their usefulness and limitations in elderly patients.

Authors:  Michèle Kiesmann; Jean-Baptiste Chanson; Julien Godet; Thomas Vogel; Laetitia Schweiger; Saïd Chayer; Georges Kaltenbach
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

4.  Differential cerebellar and cortical involvement according to various attentional load: role of educational level.

Authors:  Melissa C Bonnet; Bixente Dilharreguy; Michele Allard; Mathilde S A Deloire; Klaus G Petry; Bruno Brochet
Journal:  Hum Brain Mapp       Date:  2009-04       Impact factor: 5.038

5.  Memory impairment in Parkinson's disease.

Authors:  V V Zakharov; T V Akhutina; N N Yakhno
Journal:  Neurosci Behav Physiol       Date:  2001 Mar-Apr

Review 6.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

7.  Anticholinergic therapy and dementia in patients with Parkinson's disease.

Authors:  M Pondal; T Del Ser; F Bermejo
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

8.  The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's disease.

Authors:  Timothy J O'Brien; Virginia Wadley; Anthony P Nicholas; Natividad P Stover; Ray Watts; H Randall Griffith
Journal:  Arch Clin Neuropsychol       Date:  2009-07-08       Impact factor: 2.813

Review 9.  Cognitive deficits and psychosis in Parkinson's disease: a review of pathophysiology and therapeutic options.

Authors:  Caroline H Williams-Gray; Thomas Foltynie; Simon J G Lewis; Roger A Barker
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

10.  Cognitive decline tracks motor progression and not disease duration in Parkinson patients.

Authors:  B D Riggeal; G P Crucian; P Seignourel; C E Jacobson; M S Okun; R l Rodriguez; Hubert H Fernandez
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.